Abstract: Systems and methods for displaying content within an icon/tile associated with an executable streaming media application without launching the associated executable streaming media application are disclosed. The methods display a plurality of icons relating to streaming media applications on a home screen of a user interface. An automatic selection of one or more icons is made based on a selection criterion. Upon determining a trigger, content referenced in a manifest file is accessed and displayed within the boundaries of the selected icon. The content is selected based one or more factors. The content displayed is deep-linked to a media asset associated with the content. The manifest file is updated, and a personalized manifest file based on user consumption history and display device parameters is received. The content from the updated manifest file is played within the icon.

Abstract: Systems and methods are described for enabling payment or access validation based on the state of a user. A user may initiate a transaction at a point-of-sale device by providing a biometric input. The user's affective state is determined based on the user's biometric input. If the probability that the user is under duress is above a threshold, a supplemental action is taken (e.g., denying the transaction, flagging the transaction for review, etc.).

Abstract: The present invention relates to the identification and use of protein biomarkers with clinical relevance to kidney status and chronic renal injury or disorder. In particular, the invention provides the identity of marker proteins which are recognized by antibodies present in patients suffering from end-stage renal disorder, stable renal transplant, renal transplant glomerulopathy (TG), and interstitial fibrosis and tubular atrophy (IFTA). Methods and kits are described for using these proteins in the study and diagnosis of chronic renal transplant injury, and in the selection and/or monitoring of treatment regimens.

Abstract: The invention concerns a novel polypeptide derived from the cleavage of the BARD1 protein, a nucleic acid encoding for said polypeptide, and their diagnostic and therapeutic uses, in particular for treating tumors.

Abstract: The invention concerns a novel polypeptide derived from the cleavage of the BARD1 protein, a nucleic acid coding for said polypeptide, and their diagnostic and therapeutic uses, in particular for treating tumours.

Abstract: The invention concerns a novel polypeptide derived from the cleavage of the BARD1 protein, a nucleic acid coding for said polypeptide, and their diagnostic and therapeutic uses, in particular for treating tumours.